The shares of Pfizer Inc (NYSE:PFE) were last seen up 4.9% to trade at $24.4, after the pharmaceutical giant's second-quarter results beat expectations. The company also lifted its 2025 profit outlook, citing strength for its Covid-19 drugs as well as its Vyndaqel heart medication.Pfizer was one of the 17 companies President Donald Trump wrote to demanding lower drug prices. The firm said its current guidance absorbs the cost of tariffs and cost-cutting measures. In other news, the company will also abandon ...